secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001295947-22-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Healthcare reports record FY2022 revenue $1.087B, adj. EPS $4.06, authorizes $50M buyback
--------------------------------------------------------------------------------

- Q4 revenue $266.9M (+12.3% YoY); full-year revenue $1,086.8M (+15.2% YoY).
- Full-year GAAP diluted EPS $4.04; adjusted diluted EPS $4.06, up 25.3%.
- Record non-GAAP free cash flow $253.7M; operating cash flow $259.9M.
- Initial FY2023 outlook: revenue ~$1.125B, diluted EPS $4.18-$4.23, FCF $260M+.
- Board authorized $50M share repurchase program through May 2023; net leverage 3.8x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000012/0001295947-22-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000012/pbh-20220505.htm
  HTML page:      https://secwatch.observer/filing/0001295947-22-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer